RE:RE:RE:RE:RE:RE:RE:RE:Newbies and WhinersAre you for real? Just to start...you do know that Isodiol has been around for 3 or 4 years now right? So, yes they are a start-up still, but not as young as Tinley. Moving on now. What's stopping other companies...?? Is this a serious question? The time and effort to develop the right formulations and patented process doesn't happen over night. So, right off of the bat they would be behind. Then there is also the fact that the "companies with bigger pockets" that you speak wouldn't touch this industry with a ten foot pole right now. No company with an established brand in another sector is going to risk its brand image and fiduciary duty until marijuana is rescheduled or becomes legal at the federal level. This is a huge deterent. If you don't have the patience to sit on a long-term investment with the prospects and potential that Tinley has then you can't call yourself a true investor.
Rsupreme wrote: exactly. right on . these questions explain the Sp dropping, (not the entire reason) come Jan 1st.. what's stopping other companies.. with bigger pockets from squashing TNY before it even gets started.... i've read all i can read about the mgmt team. its time now they need to answer questions. When Tinley 27 came out.. i was like yesssss this is what i wanna see... i want reviews.. from regular people.. or a timeline at least... SP is at .25-26, and nobody is running to buy.. alot flocking over to ISOL or TGIF. im not sayin ISOL is the end all be all stock. but i mean you gotta be impresed with those numbers unaudited or not.. and thats only CBD stuff. they dont even touch THC.. imagine what they are going to do with canopy behind them. revenue by 2019 will be extremly nice. Cali is a fickle place buddy, too much competition. i hope mgmt knows what they are doing.. because they could be left behind... and i think the market knows this....